Doyle Wealth Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$540K Sell
1,113
-18,793
-94% -$9.14M 0.05% 127
2022
Q2
$9.32M Sell
19,906
-287
-1% -$128K 0.75% 51
2022
Q1
$8.79M Buy
20,193
+378
+2% +$158K 0.63% 55
2021
Q4
$9.19M Sell
19,815
-145
-0.7% -$64.2K 0.66% 57
2021
Q3
$7.77M Buy
19,960
+91
+0.5% +$38.6K 0.62% 57
2021
Q2
$8.8M Buy
19,869
+216
+1% +$94.4K 0.73% 54
2021
Q1
$8.24M Buy
19,653
+279
+1% +$111K 0.79% 49
2020
Q4
$7.95M Buy
19,374
+345
+2% +$143K 0.81% 46
2020
Q3
$7.88M Buy
+19,029
New +$7.65M 0.91% 40
2019
Q3
Sell
-32
Closed -$8K 427
2019
Q2
$8K Buy
+32
New +$8.12K ﹤0.01% 666
2019
Q1
Sell
-32
Closed -$9K 411
2018
Q4
$9K Buy
+32
New +$10.1K ﹤0.01% 639

Other funds holding HUM

Doyle Wealth Management's HUM Position: Q3 2022 in Review

Doyle Wealth Management reduced its Humana (HUM) stake by 94% in Q3 2022, selling an estimated $9.14M and leaving 1,113 shares worth $540K. The position accounts for 0.05% of the portfolio, ranked #127.

Doyle Wealth Management first reported a position in HUM in Q4 2018 and has held it in 11 quarters since. The position peaked at $9.32M in Q2 2022. 1,001 funds tracked by Wall St. Rank hold HUM as of Q3 2022.

  • Doyle Wealth Management held 1,113 shares of Humana worth $540K as of Q3 2022.
  • Doyle Wealth Management sold 18,793 Humana shares in Q3 2022, an estimated $9.14M.
  • Humana made up 0.05% of Doyle Wealth Management's portfolio in Q3 2022, its #127 holding.
  • Doyle Wealth Management first reported a position in Humana in Q4 2018 and has held it in 11 quarters since.
  • Doyle Wealth Management's Humana position peaked at $9.32M in Q2 2022.
  • 1,001 funds tracked by Wall St. Rank held Humana as of Q3 2022.

Based on Doyle Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.